Association between DNA damage, DNA repair genes variability and clinical characteristics in breast cancer patients

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 648, Issue 1-2, 2008, Pages 65-72

  Synowiec, Ewelina ^a   Stefanska, Joanna ^a   Morawiec, Zbigniew ^b   Blasiak, Janusz ^a   Wozniak, Katarzyna ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b N Copernicus Hospital   (Poland)

Author keywords

Breast cancer; DNA damage and repair; DNA repair genes polymorphism

Indexed keywords

CYTOSINE; DNA BASE; DNA FORMAMIDOPYRIMIDINE GLYCOSYLASE; ENDONUCLEASE; GLYCINE; GUANINE; LYSINE; METHIONINE; PROGESTERONE RECEPTOR; SERINE; THREONINE; TUMOR MARKER;

ADULT; ALLELE; ARTICLE; BREAST CARCINOMA; CANCER PATIENT; CLINICAL ARTICLE; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA POLYMORPHISM; DNA REPAIR; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; OGG1 GENE; ONCOGENE; OXIDATIVE STRESS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAD51 GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; XPD GENE; XRCC3 GENE;

ANIMALS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CASE-CONTROL STUDIES; CHO CELLS; COMET ASSAY; CRICETINAE; CRICETULUS; DNA DAMAGE; DNA REPAIR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 56349123228     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2008.09.014     Document Type: Article

References (42)

1. Dumitrescu R.G., and Cotarla I. Understanding breast cancer risk-where do we stand in 2005?. J. Cell Mol. Med. 9 (2005) 208-221
2. Dapic V., Carvalho M.A., and Monteiro A.N.A. Breast cancer susceptibility and the DNA damage response. Cancer Control 12 (2005) 127-136
3. Lunn R.M., Helzlsouer K.J., Parshad R., Umbach D.M., Harris E.L., Sanford K.K., and Bell D.A. XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis 21 (2000) 551-555
4. Kuschel B., Auranen A., McBride S., Novik K.L., Antoniou A., Lipscombe J.M., Day N.E., Easton D.F., Ponder B.A., and Pharoah Dunning P.D. Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum. Mol. Genet. 11 (2002) 1399-1407
5. Smith T.R., Miller M.S., Lohman K., Lange E.M., Case L.D., Mohrenweiser H.W., and Hu J.J. Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer. Cancer Lett. 190 (2003) 183-190
6. Webb P.M., Hopper J.L., Newman B., Chen X., Kelemen L., Giles G.G., Southey M.C., Chenevix-Trench G., and Spurdle A.B. Double-strand break repair gene polymorphisms and risk of breast or ovarian cancer. Cancer Epidemiol. Biomarkers Prev. 14 (2005) 319-323
7. Brewster A.M., Jorgensen T.J., Ruczinski I., Huang H.Y., Hoffman S., Thuita L., Newschaffer C., Lunn R.M., Bell D., and Helzlsouer K.J. Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer. Breast Cancer Res. Treat. 95 (2006) 73-80
8. Garcia-Closas M., Egan K.M., Newcomb P.A., Brinton L.A., Titus-Ernstoff L., Chanock S., Welch R., Lissowska J., Peplonska B., Szeszenia-Dabrowska N., Zatonski W., Bardin-Mikolajczak A., and Struewing J.P. Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland and meta-analyses. Hum. Genet. 119 (2006) 376-388
9. Zhang Y., Newcomb P.A., Egan K.M., Titus-Ernstoff L., Chanock S., Welch R., Brinton L.A., Lissowska J., Bardin-Mikolajczak A., Peplonska B., Szeszenia-Dabrowska N., Zatonski W., and Garcia-Closas M. Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Cancer Epidemiol. Biomarkers Prev. 15 (2006) 353-358
10. Crew K.D., Gammon M.D., Terry M.B., Zhang F.F., Zablotska L.B., Agrawal M., Shen J., Long C.M., Eng S.M., Sagiv S.K., Teitelbaum S.L., Neugut A.I., and Santella R.M. Polymorphisms in nucleotide excision repair genes, polycyclic aromatic hydrocarbon-DNA adducts and breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 16 (2007) 2033-2041
11. Hsu H.M., Wang H.C., Chen S.T., Hsu G.C., Shen C.Y., and Yu J.C. Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11/Rad50/Nbs1 complex. Cancer Epidemiol. Biomarkers Prev. 16 (2007) 2024-2032
12. Sangrajrang S., Schmezer P., Burkholder I., Waas P., Boffetta P., Brennan P., Bartsch H., Wiangnon S., and Popanda O. Polymorphisms in three base excision repair genes and breast cancer risk in Thai women. Breast Cancer Res. Treat. (2007)
13. Costa S., Pinto D., Pereira D., Rodrigues H., Cameselle-Teijeiro J., Medeiros R., and Schmitt F. DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population. Breast Cancer Res. Treat. 103 (2007) 209-217
14. Costa S., Pinto D., Pereira D., Rodrigues H., Cameselle-Teijeiro J., Medeiros R., and Schmitt F. XRCC1 Arg399Gln and RAD51 5′UTR G135C polymorphisms and their outcome in tumor aggressiveness and survival of Portuguese breast cancer patients. Breast Cancer Res. Treat. 109 (2008) 183-185
15. Hoeijmakers J.H.J. Genome maintenance mechanisms for preventing cancer. Nature 411 (2001) 366-374
16. Ma H., Bernstein L., Ross R.K., and Ursin G. Hormone-related risk factors for breast cancer in woman under age 50 years by estrogen and progesterone receptor status: results from a case-control and case-case comparison. Breast Cancer Res. 8 (2006) 1-10
17. Rakha E.A., El-Sayed M.E., Green A.R., Paish E.C., Powe D.G., Gee J., Nicholson R.I., Lee A.H., Robertson J.F., and Ellis I.O. Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype. J. Clin. Oncol. 25 (2007) 4772-4778
18. Arpino G., Weiss H., Lee A.V., Schiff R., De Placido S., Osborne C.K., and Elledge R.M. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance. J. Natl. Cancer Inst. 97 (2005) 1254-1261
19. Vares G., Ory K., Lectard B., Levalois C., Altmeyer-Morel S., Chevillard S., and Lebeau J. Progesterone prevents radiation-induced apoptosis in breast cancer cells. Oncogene 23 (2004) 4603-4613
20. Collins A.R., Duthie S.J., and Dobson V.L. Direct enzymatic detection of endogenous base damage in human lymphocyte DNA. Carcinogenesis 14 (1993) 1733-1735
21. David-Cordonnier M.-H., Laval J., and O'Neill P. Clustered DNA damage, influence on damage excision by XRS5 nuclear extracts and Escherichia coli Nth and Fpg proteins. J. Biol. Chem. 275 (2000) 11865-11873
22. Singh N.P., McCoy T., Tice R.R., and Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 175 (1988) 184-192
23. Evans M.D., Podmore I.D., Daly G.J., Perrett D., Lunec J., and Herbert K.E. Detection of purine lesions in cellular DNA using single cell gel electrophoresis with Fpg protein. Biochem. Soc. Trans. 23 (1995) 434S
24. Blasiak J., and Kowalik J. A comparison of the in vitro genotoxicity of tri- and hexavalent chromium. Mutat. Res. 469 (2000) 135-145
25. Sannino P., and Shousha S. Demonstration of oestrogen receptors in paraffin was sections of breast carcinoma using the monoclonal antibody 1D5 and microwave oven processing. J. Clin. Pathol. 47 (1994) 90-92
26. Parshad R., Price F.M., Bohr V.A., Cowans K.H., Zujewski J.A., and Sanford K.K. Deficient DNA repair capacity, a predisposing factor in breast cancer. Br. J. Cancer 74 (1996) 1-5
27. Thompson L.H., and Schild D. Recombinational DNA repair and human disease. Mutat. Res. 509 (2002) 49-78
28. Blasiak J., Arabski M., Krupa R., Wozniak K., Rykala J., Kolacinska A., Morawiec Z., Drzewoski J., and Zadrozny M. Basal, oxidative and alkylative DNA damage, DNA repair efficacy and mutagen sensitivity in breast cancer. Mutat. Res. 554 (2004) 139-148
29. Hussien M.M., McNulty H., Armstrong N., Johnston P.G., Spence R.A.J., and Barnett Y. Investigation of systemic folate status, impact of alcohol intake and levels of DNA damage in mononuclear cells of breast cancer patients. Br. J. Cancer 92 (2005) 1524-1530
30. Agnoletto M.H., Guecheva T.N., Donde F., de Oliveira A.F., Franke F., Cassini C., Salvador M., Henrigues J.A.P., and Saffi J. Association of low repair efficiency with high hormone receptors expression and SOD activity in breast cancer patients. Clin. Biochem. 40 (2007) 1252-1258
31. Alapetite C., Thirion P., de la Rochefordiere A., Cosser J.M., and Moustacchi E. Analysis by alkaline comet assay of cancer patients with sever reactions to radiotherapy: defective rejoining of radioinduced DNA strand breaks in lymphocytes of breast cancer patients. Int. J. Cancer 83 (1999) 83-90
32. Muller-Vogt U.S., Maurer J.E.E., Grabenbauer G.G., Distel L.V.R., Iro H., and Steinhart H. Altered DNA repair capacity in young patients suffering from multiple cancer. Int. J. Mol. Med. 11 (2003) 669-674
33. Djuzenova C.S., Muhl B., Fehn M., Oppitz U., Muller B., and Flentje M. Radio-sensitivity in breast cancer assessed by the comet assay and micronucleus assays. Br. J. Cancer 94 (2006) 1194-1203
34. Musarrat J., Arezina-Wilson J., and Wani A.A. Prognostic and aetiological relevance of 8-hydroxyguanosine in human breast carcinogenesis. Eur. J. Cancer 32A (1996) 1209-1214
35. Mobley J.A., and Brueggemeier R.W. Estrogen receptor-mediated regulation of oxidative stress and DNA damage in breast cancer. Carcinogenesis 25 (2004) 3-9
36. Itagaki T., Shimizu I., Cheng X., Yuan Y., Oshio A., Tamaki K., Fukuno H., Honda H., Okamura Y., and Ito S. Opposing effects of oestradiol and progesterone on intracellular pathways and activation processes in the oxidative stress induced activation of cultured rat hepatic stellate cells. Gut 54 (2005) 1782-1789
37. Ralhan R., Kaur J., Kreienberg R., and Wiesmuller L. Links between DNA double strand break repair and breast cancer: accumulating evidence from both familial and nonfamilial cases. Cancer Lett. 248 (2007) 1-17
38. Levy-Lahad E., Lahad A., Eisenberg S., Dagan E., Paperna T., Kasinetz L., Catane R., Kaufaman B., Beller U., Renbaum P., and Gershoni-Baruch R. A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 3232-3236
39. Blasiak J., Przybylowska K., Czechowska A., Zadrozny M., Pertynski T., Rykala J., Kolacinska A., Morawiec Z., and Drzewoski J. Analysis of the G/C polymorphism in the 5′-untranslated region of the RAD51 gene in breast cancer. Acta Biochim. Pol. 50 (2003) 249-253
40. Sliwinski T., Krupa R., Majsterek I., Rykala J., Kolacinska A., Morawiec Z., Drzewoski J., Zadrozny M., and Blasiak J. Polymorphisms of the BRCA2 and RAD51 genes in breast cancer. Breast Cancer Res. Treat. 94 (2005) 105-109
41. Antoniou A.C., Sinilnikova O.M., Simard J., Leone M., Dumont M., Neuhausen S.L., et al. RAD51 135G → C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Am. J. Hum. Genet. 81 (2007) 1186-1200
42. Jakubowska A., Gronwald J., Menkiszak J., Gorski B., Huzarski T., Byrski T., Edler L., Lubinski J., Scott R.J., and Hamann U. The RAD51 135 G > C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers. Cancer Epidemiol. Biomarkers Prev. 16 (2007) 270-275